Skip to main content
Back
Watch Compare

Gain Therapeutics, Inc.

GANX
Nasdaq Manufacturing Chemicals
$1.80
▼ $0.04 (-2.17%)
Mkt Cap: 78.39 M
Price
$1.85
Mkt Cap
78.39 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Price History

Financial Trends

Analyst Price Target

5 analysts
Buy
Current
$1.80
+322.2%
Target
$7.60
$5.00
$8.00
$10.00
Forecast
Forward P/E -2.89
Forward EPS -$0.62
Est. Revenue 0.0

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$0.62
-$0.74 – -$0.47
 0.0 3
FY2026 -$0.61
-$0.79 – -$0.50
 0.0 4

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$0.15 -$0.11 +24.1%
Q32025 -$0.15 -$0.15 +2.2%
Q22025 -$0.17 -$0.19 -11.8%
Q12025 -$0.17 -$0.16 +4.0%

ETFs Holding This Stock

BRSIX BRSIX
0.06% weight

No fundamental snapshot available yet.

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — 55,180.0 55,180.0 140,108.0 164,994.0
Net Income -20.16 M -20.41 M -22.27 M -17.59 M -13.89 M
EPS (Diluted) -0.61 -0.89 -1.71 -1.48 -1.37
Gross Profit — — — — —
Operating Income -18.71 M -20.35 M -22.25 M -17.78 M -13.83 M
EBITDA — — — — —
R&D Expenses 10.21 M 10.79 M 11.52 M 8.38 M 7.16 M
SG&A Expenses — — — — —
D&A 94,046.0 84,071.0 83,579.0 64,168.0 15,484.0
Interest Expense — — 494,234.0 375,357.0 0.0
Income Tax 861,118.0 536,815.0 79,275.0 92,976.0 4,008.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 22.82 M 12.12 M 18.61 M 24.10 M 38.99 M
Total Liabilities 4.25 M 4.78 M 6.03 M 5.22 M 4.17 M
Shareholders' Equity 18.56 M 7.34 M 12.58 M 18.88 M 34.82 M
Total Debt 400,953.0 438,504.0 567,850.0 603,393.0 694,294.0
Cash & Equivalents 20.84 M 10.39 M 11.79 M 7.31 M 36.88 M
Current Assets 22.24 M 11.60 M 17.78 M 21.09 M 37.72 M
Current Liabilities 3.35 M 3.91 M 4.95 M 4.13 M 2.55 M